| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Four cannabis stocks are demonstrating significant technical momentum, seemingly undeterred by new regulatory headwinds from Washington.
The positive trend comes even as Congress passed a government funding bill that includes a controversial provision to re-criminalize many popular hemp-derived THC products, a move that could disrupt a large segment of the market.
The stocks logging the gains include Tilray Brands Inc. (NASDAQ:TLRY), Cronos Group Inc. (NASDAQ:CRON), Organigram Global Inc. (NASDAQ:OGI), and SNDL Inc. (NASDAQ:SNDL).
According to Benzinga Edge’s Stock Rankings, which measure a stock’s relative price strength over multiple timeframes, all four companies show strong positive momentum.
This technical strength is supported by their recent performance, particularly over the last six months.
| Stock | Benzinga Momentum Ranking | 6-Month Return | YTD Return | One-Year Return |
| TLRY | 92.08 (Green) | 156.82% | -22.60% | -18.12% |
| CRON | 71.16 (Green) | 20.39% | 20.39% | 19.81% |
| OGI | 67.70 (Green) | 26.23% | -7.23% | 2.67% |
| SNDL | 66.34 (Green) | 32.81% | 32.81% | -12.82% |


See Also: From Azure Darling To Momentum Dog: C3.ai’s Plunging Score Signals Partner Risk


The momentum contrasts sharply with a new legislative threat embedded in the funding package that ended the recent government shutdown. A last-minute provision effectively re-criminalizes intoxicating hemp products, such as Delta-8, that were legalized under the 2018 Farm Bill.
Senator Rand Paul (R-KY) criticized the provision, warning it "wipes out nearly 100% of legal hemp products overnight" and would crush farmers.
The impact on the industry is complex, as it could benefit multi-state operators by eliminating “gray-market” competition.
However, it is expected to hit Canadian players like Tilray, which had viewed the hemp-derived product segment as a key pathway into the U.S. market.
Read Next:
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Image via Shutterstock